Results 101 to 110 of about 11,830 (209)

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

open access: yes, 2011
Thiopurine methyltransferase (TPMT) activity exhibits monogenic co-dominant inheritance, with ethnic differences in the frequency of occurrence of variant alleles.
W E Evans   +19 more
core   +1 more source

Usefulness of thiopurine methyltransferase and thiopurine metabolite analysis in clinical practice in patients with inflammatory bowel diseases.

open access: yes, 2010
Thiopurines (TP) are widely used in the management of inflammatory bowel diseases. Side-effects and inefficacy are a major concern as they lead to withdrawal of the drug.
Dewit, Olivier
core  

Let's get personal:predicting thiopurine and fluoropyrimidine toxicity

open access: yes, 2012
The US FDA now recognizes the need to individualize treatment paradigms using biomarkers that predict response to therapy. In clinical practice the best example of this is TPMT testing, which is used to rationalize the starting dose of azathioprine and ...
Corrigan, Adele   +4 more
core   +1 more source

Blood-test monitoring strategies for patients established on immune-suppressing drugs: a mixed-methods study

open access: yesHealth Technology Assessment
Background The optimal monitoring strategy for adults with inflammatory conditions established on immune-suppressing treatment is unknown. Objectives To ascertain the optimum strategy of monitoring blood tests for patients established on immune ...
Abhishek Abhishek   +17 more
doaj   +1 more source

Thiopurine S-methyltransferase – An important intersection of drug-drug interactions in thiopurine treatment

open access: yesBiomedicine & Pharmacotherapy
Understanding the molecular mechanisms of medicines is crucial for developing novel drugs, for repurposing existing medicines, and for predicting toxicities. Thiopurine S-methyltransferase (TPMT) serves as an exemplary case in personalized medicine, as its activity is influenced by genetic variants, co-factors, substrates, and inhibitors, which lead to
Dunja Urbančič   +5 more
openaire   +3 more sources

Association between the c.415C > T, c.52G > A, and 36_37insGGAGTC polymorphisms of NUDT 15 and thiopurine-induced leukopenia, thiopurine intolerance, and severe hair loss: an updated meta-analysis

open access: yesDrug Design, Development and Therapy, 2019
Ruili Wang,1,2 Baogang Liu,2 Jiapeng Li,1 Jiamin Xu,1 Xiaoling Wang,1 Zhigang Zhao,2 Libo Zhao11Clinical Research Center, Beijing Children’s Hospital, National Center for Children’s Health, Capital Medical University, Beijing, People’s ...
Wang R   +6 more
doaj  

Pharmacogenetic studies of thiopurines : focus on thiopurine methyltransferase

open access: yes, 2005
Pharmacogenetics represents the study ofvariability in drug response due to genetic variations. The thiopurines (6-mercaptopurine, 6-thioguanine and azathioprine) are prodrugs which require metabolic transformation to exert effect. Thiopurines are used in inflammatory bowel disease, as maintenance treatment of childhood acute lymphoblastic leukaemia ...
openaire   +1 more source

Clinical significance of thiopurine S-methyltransferase gene polymorphisms

open access: yes, 2007
Thiopurine methyltransferase (TPMT) is an important enzyme that catalyzes the S-methylation of a series of thiopurine drugs, including 6-mercaptopurine (6-MP), thioguanine and azathiopurine (AZA), to generate inactive methylated metabolites.
Balram Chowbay (110465)   +1 more
core  

Thiopurine 약물치료를 받고 있는 한국의 염증성 장질환 환자들의 Thiopurine Methyltransferase와 Inosine Triphosphate Pyrophosphatase의 유전자형과 장기간 치료 반응과의 상관관계

open access: yes, 2010
Dept. of Medicine/석사[한글] [영문]Background and Aims: There is a lack of research describing associations between thiopurine methyltransferase (TPMT)/inosine triphosphate pyrophosphatase (ITPA) genotypes or phenotypes and long-term clinical outcomes after ...
정윤숙
core  

Home - About - Disclaimer - Privacy